Details for New Drug Application (NDA): 062592
✉ Email this page to a colleague
The generic ingredient in KEFUROX is cefuroxime sodium. There are sixty-two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the cefuroxime sodium profile page.
Summary for 062592
Tradename: | KEFUROX |
Applicant: | Lilly |
Ingredient: | cefuroxime sodium |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INTRAVENOUS | Strength | EQ 750MG BASE/VIAL | ||||
Approval Date: | Jan 10, 1986 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1.5GM BASE/VIAL | ||||
Approval Date: | Jan 10, 1986 | TE: | RLD: | No |
Complete Access Available with Subscription